...
首页> 外文期刊>Journal of Gastrointestinal Surgery >Treatment of High Output Cardiac Failure by Flow-Adapted Hepatic Artery Banding (FHAB) in Patients with Hereditary Hemorrhagic Telangiectasia
【24h】

Treatment of High Output Cardiac Failure by Flow-Adapted Hepatic Artery Banding (FHAB) in Patients with Hereditary Hemorrhagic Telangiectasia

机译:遗传性出血性毛细血管扩张症患者的血流适应性肝动脉束带(FHAB)治疗高输出心脏衰竭

获取原文
获取原文并翻译 | 示例

摘要

Involvement of abdominal organs in Osler’s disease may lead to the development of hepatic arteriovenous shunts with a dilatation of the hepatic artery. Right and subsequent global heart failure due to cardiac valvular insufficiency, pulmonary artery hypertension, and hepatomegaly as well as increased cardiac output may result. This hyperdynamic hepatic blood flow can be reduced by ligature or banding of the hepatic artery or by orthotopic liver transplantation. We report on two female patients suffering from Osler’s disease (68 and 76 years old) with severe heart insufficiency (NYHA III-IV) caused by the high hepatic shunt volumes. A gradual banding of the hepatic artery directed by intraoperative flow measurement in the hepatic artery and control of the systemic hemodynamics by Swan–Ganz or COLD catheters was performed in these patients. The banding was achieved by encasing the hepatic artery in a PTFE cuff (length, 1.0 cm). The high cardiac output could be reduced from 11.2 to 7.0 l/min and from 10.7 to 6.0 l/min, respectively. The respective hepatic artery flow was reduced from 2.0 to 0.3 l/min and from 4.0 to 0.7 l/min. An improvement of heart insufficiency, a reduction in the severity of the cardiac valvular insufficiency, and a reduction of the pulmonary arterial hypertension could be already observed intraoperatively. One patient died of right cardiac failure after an orthotopic liver transplantation 7 months later. The other one died 3 years after the banding. The banding of the hepatic artery controlled by hepatic arterial flow measurement can be considered as an effective and safe palliative procedure in intrahepatic HHT compared to therapeutic alternatives such as hepatic artery ligation or embolization.
机译:腹部器官参与Osler病可能会导致肝动静脉分流并伴随肝动脉扩张。可能会导致由于心脏瓣膜功能不全,肺动脉高压和肝肿大而导致的右旋及随后的整体心力衰竭,以及心输出量增加。通过肝动脉的结扎或绑扎或通过原位肝移植可以减少这种高动力性肝血流量。我们报道了两名女性患者,这些患者患有由高分流导致的严重心功能不全(Osler病)(68岁和76岁)的奥斯勒氏病(NYHA III-IV)。在这些患者中,通过术中肝动脉血流测量引导肝动脉逐渐包扎,并通过Swan-Ganz或COLD导管控制全身血流动力学。通过将肝动脉包裹在PTFE套囊中(长度为1.0 cm)来实现绑扎。高心输出量可以分别从11.2降到7.0 l / min和从10.7降到6.0 l / min。相应的肝动脉流量从2.0降至0.3 l / min,从4.0降至0.7 l / min。术中已经可以观察到心脏功能不全的改善,心脏瓣膜功能不全的严重程度的降低以及肺动脉高压的降低。 7个月后原位肝移植后,一名患者死于右心衰竭。另一人在绑扎3年后死亡。与肝动脉结扎或栓塞等治疗方法相比,通过肝动脉血流测量控制的肝动脉束带可被认为是肝内HHT的一种有效且安全的姑息治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号